Research And Markets - View These Extensive Reviews Focused On Pharmacology, Pharmacokinetics, Toxicology, And Clinical Trials Of New Or Potential Cardiovascular Drugs

Research and Markets (researchandmarkets.com/reports/c9291) has announced the addition of Cardiovascular Drug Reviews to their offering.

(PRWEB) November 17, 2004 -- Cardiovascular Drug Reviews focuses on extensive reviews on the pharmacology, pharmacokinetics, toxicology, and clinical trials of new or potential cardiovascular drugs. These peer-reviewed articles are written by industrial or academic scientists who participated in the development of a particular drug. The Editorial Board is composed of eminent and highly reputable scientists.

Research and Markets (http://www.researchandmarkets.com/reports/c9291) has announced the addition of Cardiovascular Drug Reviews to their offering.

Subscribe to Cardiovascular Drug Reviews to receive:

- Timely summaries of clinical studies for newly FDA approved or potential drugs.

- Insight into the biological activity of novel chemical entities.

- Valuable information on pharmacokinetics and associated ADME properties.

You Should Subscribe to Cardiovascular Drug Reviews to:

- Identify toxicity and suboptimal characteristics as competitive opportunities.

- Recognize actionable information across all functional areas, including discovery, development, and clinical use.

- Be up-to-date on new drug developments most significantly affecting the cardiovascular drug market.

- Receive quality information on new drugs that is peer-reviewed by an eminent, international Editorial Board.

The following individuals will benefit from a subscription to Cardiovascular Drug Reviews:

- Cardiologists

- Clinical Pharmacologists

- Drug Development Scientists

- Internists

- Medicinal Chemists

- Pharmaceutical Industry Executives

- Pharmacologists

- Toxicologists

For more information visit http://www.researchandmarkets.com/reports/c9291

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###